HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Inner Glow Vitamins Launches Latest Sun Protection In A Pill

Executive Summary

Sun protection is not an unheard-of claim in the dietary supplement space, but it has proven a problematic one from regulatory and legal standpoints.

You may also be interested in...



Supplement Firms Making Sunscreen Claims Warned In FDA Crackdown

Claims that rendered the firms' products unapproved new drugs and were listed in FDA warning letters include "It’s basically an oral sunscreen … This would be especially useful for people who have had skin cancer, are at risk for skin cancer.” The firms FDA warned are Isocell North America Inc., Sunergized LLC, Pharmacy Direct Inc. and Napa Valley Bioscience LLC.

Long Time Coming? Drinkable Sunscreen Maker Sued For Fraud

Osmosis Pür Medical Skincare has been marketing a drinkable UV Neutralizer for around five years as part of its Harmonized H2O line. Skeptics abound, including the American Academy of Dermatology, but the company appears to have eluded litigation prior to the Iowa attorney general’s suit filed March 14.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151238

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel